Sodium Chloride 0.9% IV with Fleboflex®
Fluid replacement, infusion therapy
ApprovedActive
Key Facts
Indication
Fluid replacement, infusion therapy
Phase
Approved
Status
Active
Company
About NextGen Pharmaceuticals
NextGen Pharmaceuticals is a private, commercial-stage company specializing in generic injectable pharmaceuticals, particularly IV saline solutions. It positions itself as a reliable partner for healthcare providers, leveraging its Fleboflex® packaging technology to enhance product safety and handling. The company's strategy centers on mitigating supply chain volatility for essential medical supplies and building long-term relationships with healthcare institutions. Its core market focus includes infusion therapy, with an emphasis on supporting oncology and immunosuppressant treatment areas.
View full company profile